Effects of intermittent parathyroid hormone treatment on new bone formation during distraction osteogenesis in the rat mandible

Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology

Volumn 114, Issue 1, 2012, Pages

  Ali, Mir Nowazesh ^a   Kobayashi, Tadaharu ^b   Tanaka, Mikako ^b   Ohshima, Hayato ^b   Ejiri, Sadakazu ^c   Saito, Chikara ^b  

^a BANGABANDHU SHEIKH MUJIB MEDICAL UNIVERSITY   (Bangladesh)

^b NIIGATA UNIVERSITY   (Japan)

^c ASAHI UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PARATHYROID HORMONE;

ANIMAL; ANIMAL MODEL; ARTICLE; BONE REGENERATION; DISTRACTION OSTEOGENESIS; DRUG EFFECT; MALE; MANDIBLE; MICRO-COMPUTED TOMOGRAPHY; OSTEOTOMY; RADIOGRAPHY; RAT; THREE DIMENSIONAL IMAGING; WISTAR RAT;

ANIMALS; BONE REGENERATION; IMAGING, THREE-DIMENSIONAL; MALE; MANDIBLE; MODELS, ANIMAL; OSTEOGENESIS, DISTRACTION; OSTEOTOMY; PARATHYROID HORMONE; RATS; RATS, WISTAR; X-RAY MICROTOMOGRAPHY;

EID: 84862670481     PISSN: 22124403     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.oooo.2011.08.009     Document Type: Article

References (32)

1. M.M. Mofid, P.N. Manson, B.C. Robertson, A.P. Tufaro, J.J. Elias, C.A. Vander Kolk Distraction osteogenesis: a review of 3278 cases Plast Reconstr Surg 108 2001 1103 1114
2. W.H. Schreuder, J. Jansma, M.W. Bierman, A. Vissink Distraction osteogenesis versus bilateral sagittal split osteotomy for advancement of the retrognathic mandible: a review of the literature Int J Oral Maxillofac Surg 36 2007 103 110
3. J.G. McCarthy, J. Schreiber, N. Karp, C.H. Thorne, B.H. Grayson Lengthening the human mandible by gradual distraction Plast Reconstr Surg 89 1992 1 8
4. A. Rachmiel, M. Levy, D. Laufer Lengthening of the mandible by distraction osteogenesis: report of cases J Oral Maxillofac Surg 53 1995 838 846
5. C. Klein, H.P. Howaldt Correction of mandibular hypoplasia by means of bidirectional callus distraction J Craniofac Surg 7 1996 258 266
6. M.D. Vos, E.M. Baas, J. de Lange, F. Bierenbroodspot Stability of mandibular advancement procedures: bilateral sagittal split osteotomy versus distraction osteogenesis Int J Oral Maxillofac Surg 38 2009 7 12
7. B.H. Mitlak Parathyroid hormone as a therapeutic agent Curr Opin Pharmacol 2 2002 694 699
8. M.R. Rubin, F. Cosman, R. Lindsay, J.P. Bilezikian The anabolic effects of parathyroid hormone Osteoporos Int 13 2002 267 277
9. R. Aleksyniene, I. Hvid Parathyroid hormone - possible future drug for orthopedic surgery Medicina (Kaunas) 40 2004 842 849
10. K.L. Hamann, N.E. Lane Parathyroid hormone update Rheum Dis Clin North Am 32 2006 703 719
11. T.T. Andreassen, C. Ejersted, H. Oxlund Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures J Bone Miner Res 14 1999 960 968
12. A. Nakajima, N. Shimoji, K. Shiomi, S. Shimizu, H. Moriya, T.A. Einhorn Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34) J Bone Miner Res 17 2002 2038 2047
13. T.T. Andreassen, G.E. Willick, P. Morley, J.F. Whitfield Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase Calcif Tissue Int 74 2004 351 356
14. Y.M. Alkhiary, L.C. Gerstenfeld, E. Krall, M. Westmore, M. Sato, B.H. Mitlak Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34) J Bone Joint Surg Am 87 2005 731 741
15. T. Nakazawa, A. Nakajima, K. Shiomi, H. Moriya, T.A. Einhorn, M. Yamazaki Effects of low-dose, intermittent treatment with recombinant human parathyroid hormone (1-34) on chondrogenesis in a model of experimental fracture healing Bone 37 2005 711 719
16. K. Nozaka, N. Miyakoshi, Y. Kasukawa, S. Maekawa, H. Noguchi, Y. Shimada Intermittent administration of human parathyroid hormone enhances bone formation and union at the site of cancellous bone osteotomy in normal and ovariectomized rats Bone 42 2008 90 97
17. S.V. Bukata, J.E. Puzas Orthopedic uses of teriparatide Curr Osteoporos Rep 8 2010 28 33
18. R. Aleksyniene, H. Eckardt, K. Bundgaard, M. Lind, I. Hvid Effects of parathyroid hormone on newly regenerated bone during distraction osteogenesis in a rabbit tibial lengthening model A pilot study Medicina (Kaunas) 42 2006 38 48
19. C. Seebach, R. Skripitz, T.T. Andreassen, P. Aspenberg Intermittent parathyroid hormone (1-34) enhances mechanical strength and density of new bone after distraction osteogenesis in rats J Orthop Res 22 2004 472 478
20. R. Aleksyniene, J.S. Thomsen, H. Eckardt, K.G. Bundgaard, M. Lind, I. Hvid Parathyroid hormone PTH(1-34) increases the volume, mineral content, and mechanical properties of regenerated mineralizing tissue after distraction osteogenesis in rabbits Acta Orthop 80 2009 716 723
21. M.N. Ali, S. Ejiri, T. Kobayashi, D.B. Anwar, K. Oda, H. Ohshima Histological study of the cellular events during rat mandibular distraction osteogenesis Oral Surg Oral Med Oral Pathol Oral Radiol Endod 107 2009 325 335
22. M. Nakajima, S. Ejiri, M. Tanaka, E. Toyooka, S. Kohno, H. Ozawa Effect of intermittent administration of human parathyroid hormone (1-34) on the mandibular condyle of ovariectomized rats J Bone Miner Metab 18 2000 9 17
23. A. Iida-Klein, H. Zhou, S.S. Lu, L.R. Levine, M. Ducayen-Knowles, D.W. Dempster Anabolic action of parathyroid hormone is skeletal site specific at the tissue and cellular levels in mice J Bone Miner Res 17 2002 808 816
24. D.W. Dempster, F. Cosman, M. Parisien, V. Shen, R. Lindsay Anabolic actions of parathyroid hormone on bone Endocr Rev 14 1993 690 709
25. S. Nishida, A. Yamaguchi, T. Tanizawa, N. Endo, T. Mashiba, Y. Uchiyama Increased bone formation by intermittent parathyroid hormone administration is due to the stimulation of proliferation and differentiation of osteoprogenitor cells in bone marrow Bone 15 1994 717 723
26. H. Sowa, H. Kaji, M.F. Iu, T. Tsukamoto, T. Sugimoto, K. Chihara Parathyroid hormone-Smad3 axis exerts anti-apoptotic action and augments anabolic action of transforming growth factor beta in osteoblasts J Biol Chem 278 2003 52,240-52
27. N. Miyakoshi, Y. Kasukawa, T.A. Linkhart, D.J. Baylink, S. Mohan Evidence that anabolic effects of PTH on bone require IGF-I in growing mice Endocrinology 142 2001 4349 4356
28. M. Yamaguchi, N. Ogata, Y. Shinoda, T. Akune, S. Kamekura, Y. Terauchi Insulin receptor substrate-1 is required for bone anabolic function of parathyroid hormone in mice Endocrinology 146 2005 2620 2628
29. B. Lecka-Czernik, I. Gubrij, E.J. Moerman, O. Kajkenova, D.A. Lipschitz, S.C. Manolagas Inhibition of Osf2/Cbfa1 expression and terminal osteoblast differentiation by PPARgamma2 J Cell Biochem 74 1999 357 371
30. T. Bellido, A.A. Ali, L.I. Plotkin, Q. Fu, I. Gubrij, P.K. Roberson Prosteasomal degradation of Runx2 shortens parathyroid hormone-induced anti-apoptotic signaling in osteoblasts A putative explanation for why intermittent administration is needed for bone anabolism J Biol Chem 278 2003 259 272
31. V.Z. Borba, N.C. Mañas The use of PTH in the treatment of osteoporosis Arq Bras. Endocrinol Metab 54 2010 213 219
32. J.L. Vahle, M. Sato, G.G. Long, J.K. Young, P.C. Francis, J.A. Engelhardt Skeletal changes in rats given daily subcutaneous injections of recombinant human parathyroid hormone (1-34) for 2 years and relevance to human safety Toxicol Pathol 30 2002 312 321